+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Skin Cancer Dermatology Market by Cancer Type, Treatment Modality, Therapeutic Class, End User, Distribution Channel - Global Forecast to 2030- Product Image
Skin Cancer Dermatology Market by Cancer Type, Treatment Modality, Therapeutic Class, End User, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Skin Cancer Dermatology Market by Cancer Type, Treatment Modality, Therapeutic Class, End User, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 189 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011764
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The skin cancer dermatology market is evolving rapidly, shaped by clinical advances, changing patient profiles, and new care delivery models. Senior leaders must navigate a complex landscape marked by innovation, demographic trends, and evolving reimbursement strategies to identify opportunities and mitigate emerging risks.

Market Snapshot: Skin Cancer Dermatology Market

The Skin Cancer Dermatology Market grew from USD 8.42 billion in 2024 to USD 9.03 billion in 2025. It is expected to continue growing at a CAGR of 7.28%, reaching USD 12.84 billion by 2030. This robust expansion is fueled by the increasing prevalence of skin cancer worldwide, with rising ultraviolet exposure and aging populations driving incidence across all major subtypes. Growing demand for specialized treatments and next-generation therapeutics is underpinning steady adoption within global healthcare systems. The market reflects dynamic shifts as pharmaceutical innovation and emerging medical technologies strengthen the clinical and economic case for investment.

Scope & Segmentation

  • Cancer Types: Basal cell carcinoma, melanoma, squamous cell carcinoma
  • Treatment Modalities: Photodynamic therapy, radiotherapy, cryosurgery, curettage and electrodesiccation, excisional surgery, Mohs surgery, topical medications
  • Therapeutic Classes: Chemotherapy agents, immunotherapies including checkpoint inhibitors, cytokine therapies, oncolytic viruses, photodynamic agents, targeted therapies
  • End Users: Ambulatory surgical centers, dermatology clinics, hospitals
  • Distribution Channels: Hospital pharmacies, online pharmacies, retail pharmacies
  • Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, South Africa, and others), Asia-Pacific (China, India, Japan, Australia, South Korea, and more)
  • Top Market Participants: Merck & Co., Inc., Bristol-Myers Squibb Company, Roche Holding AG, Novartis AG, Amgen Inc., AstraZeneca PLC, Pfizer Inc., Sanofi S.A., Eli Lilly and Company, GlaxoSmithKline plc

Key Takeaways for Decision-Makers

  • Therapeutic innovation, particularly in immunotherapies and combination regimens, is setting new standards of care and altering competitive dynamics.
  • Digital health tools, including teledermatology and AI-supported imaging, are expanding patient access and optimizing care coordination for skin cancer management.
  • Regional differences in infrastructure and policy shape market entry and pricing strategies, making localized approaches critical for sustainable growth.
  • The growing complexity and range of targeted therapies demand refined stakeholder engagement and a nuanced understanding of clinical preferences.
  • Collaborative models, such as industry-academic partnerships and supply chain alliances, are increasingly influential in expediting innovation and market penetration.

Tariff Impact: Navigating US Market Complexities

Recent US tariffs introduced in 2025 have affected the cost structure for imported pharmaceuticals and medical devices. This has led to disruptions in sourcing active ingredients for immunotherapies, photodynamic agents, and certain surgical equipment. Providers and distributors must balance margin pressures with uninterrupted patient access by reassessing logistics, exploring domestic production, and forming strategic purchasing alliances. For leaders, proactive planning across procurement, reimbursement, and stakeholder collaboration will help address volatility and safeguard continuity of care.

Methodology & Data Sources

This report integrates peer-reviewed literature, clinical trial data, regulatory filings, and industry publications. Insights are validated through interviews with clinicians, procurement professionals, and payer representatives across target geographies. Rigorous data triangulation and adherence to ethical research standards underpin the credibility of all conclusions.

Why This Report Matters

  • Offers actionable insights to support investment in pipeline expansion, partnership strategy, and differentiated product positioning.
  • Equips leaders with granular segmentation, technology adoption analysis, and regional intelligence to inform go-to-market strategies.
  • Supports risk assessment and scenario planning by contextualizing regulatory, supply chain, and competitive market shifts.

Conclusion

The skin cancer dermatology market is transitioning through significant change, requiring adaptive strategies and evidence-based decision-making. Senior stakeholders will benefit from comprehensive, data-driven analysis to seize evolving opportunities and proactively manage sector challenges.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Skin Cancer Dermatology Market, by Cancer Type
8.1. Introduction
8.2. Basal Cell Carcinoma
8.3. Melanoma
8.4. Squamous Cell Carcinoma
9. Skin Cancer Dermatology Market, by Treatment Modality
9.1. Introduction
9.2. Photodynamic Therapy
9.3. Radiotherapy
9.4. Surgical Procedures
9.4.1. Cryosurgery
9.4.2. Curettage and Electrodesiccation
9.4.3. Excisional Surgery
9.4.4. Mohs Surgery
9.5. Topical Medications
10. Skin Cancer Dermatology Market, by Therapeutic Class
10.1. Introduction
10.2. Chemotherapy Agents
10.3. Immunotherapies
10.3.1. Checkpoint Inhibitors
10.3.2. Cytokine Therapies
10.3.3. Oncolytic Viruses
10.4. Photodynamic Agents
10.5. Targeted Therapies
11. Skin Cancer Dermatology Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Dermatology Clinics
11.4. Hospitals
12. Skin Cancer Dermatology Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacies
12.3. Online Pharmacies
12.4. Retail Pharmacies
13. Americas Skin Cancer Dermatology Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Skin Cancer Dermatology Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Skin Cancer Dermatology Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Merck & Co., Inc.
16.3.2. Bristol-Myers Squibb Company
16.3.3. Roche Holding AG
16.3.4. Novartis AG
16.3.5. Amgen Inc.
16.3.6. AstraZeneca PLC
16.3.7. Pfizer Inc.
16.3.8. Sanofi S.A.
16.3.9. Eli Lilly and Company
16.3.10. GlaxoSmithKline plc
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. SKIN CANCER DERMATOLOGY MARKET MULTI-CURRENCY
FIGURE 2. SKIN CANCER DERMATOLOGY MARKET MULTI-LANGUAGE
FIGURE 3. SKIN CANCER DERMATOLOGY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. SKIN CANCER DERMATOLOGY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. SKIN CANCER DERMATOLOGY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SKIN CANCER DERMATOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY BASAL CELL CARCINOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY MELANOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY SQUAMOUS CELL CARCINOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY PHOTODYNAMIC THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY RADIOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY CRYOSURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY CURETTAGE AND ELECTRODESICCATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY EXCISIONAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY MOHS SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY TOPICAL MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY CHEMOTHERAPY AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY CHECKPOINT INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY CYTOKINE THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY ONCOLYTIC VIRUSES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY PHOTODYNAMIC AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY TARGETED THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SKIN CANCER DERMATOLOGY MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 53. CANADA SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 54. CANADA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 55. CANADA SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 56. CANADA SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 57. CANADA SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2030 (USD MILLION)
TABLE 58. CANADA SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. CANADA SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. MEXICO SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 61. MEXICO SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 62. MEXICO SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 63. MEXICO SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 64. MEXICO SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2030 (USD MILLION)
TABLE 65. MEXICO SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. MEXICO SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 89. UNITED KINGDOM SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 90. UNITED KINGDOM SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 91. UNITED KINGDOM SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 92. UNITED KINGDOM SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 93. UNITED KINGDOM SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2030 (USD MILLION)
TABLE 94. UNITED KINGDOM SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. UNITED KINGDOM SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. GERMANY SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 97. GERMANY SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 98. GERMANY SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 99. GERMANY SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 100. GERMANY SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2030 (USD MILLION)
TABLE 101. GERMANY SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. GERMANY SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. FRANCE SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 104. FRANCE SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 105. FRANCE SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 106. FRANCE SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 107. FRANCE SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2030 (USD MILLION)
TABLE 108. FRANCE SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. FRANCE SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 110. RUSSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 111. RUSSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 112. RUSSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 113. RUSSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 114. RUSSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2030 (USD MILLION)
TABLE 115. RUSSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. RUSSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. ITALY SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 118. ITALY SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 119. ITALY SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 120. ITALY SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 121. ITALY SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2030 (USD MILLION)
TABLE 122. ITALY SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. ITALY SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 124. SPAIN SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 125. SPAIN SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 126. SPAIN SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 127. SPAIN SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 128. SPAIN SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2030 (USD MILLION)
TABLE 129. SPAIN SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. SPAIN SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 131. UNITED ARAB EMIRATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 132. UNITED ARAB EMIRATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 133. UNITED ARAB EMIRATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 134. UNITED ARAB EMIRATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 135. UNITED ARAB EMIRATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2030 (USD MILLION)
TABLE 136. UNITED ARAB EMIRATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. UNITED ARAB EMIRATES SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. SAUDI ARABIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 139. SAUDI ARABIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 140. SAUDI ARABIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 141. SAUDI ARABIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 142. SAUDI ARABIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2030 (USD MILLION)
TABLE 143. SAUDI ARABIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. SAUDI ARABIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. SOUTH AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 146. SOUTH AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 147. SOUTH AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 148. SOUTH AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 149. SOUTH AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2030 (USD MILLION)
TABLE 150. SOUTH AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. SOUTH AFRICA SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. DENMARK SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 153. DENMARK SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 154. DENMARK SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 155. DENMARK SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 156. DENMARK SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2030 (USD MILLION)
TABLE 157. DENMARK SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. DENMARK SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. NETHERLANDS SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 160. NETHERLANDS SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 161. NETHERLANDS SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 162. NETHERLANDS SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 163. NETHERLANDS SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. QATAR SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 167. QATAR SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 168. QATAR SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 169. QATAR SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 170. QATAR SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2030 (USD MILLION)
TABLE 171. QATAR SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. QATAR SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. FINLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 174. FINLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 175. FINLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 176. FINLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 177. FINLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2030 (USD MILLION)
TABLE 178. FINLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. FINLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. SWEDEN SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 181. SWEDEN SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 182. SWEDEN SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 183. SWEDEN SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 184. SWEDEN SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2030 (USD MILLION)
TABLE 185. SWEDEN SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. SWEDEN SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 187. NIGERIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 188. NIGERIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 189. NIGERIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 190. NIGERIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 191. NIGERIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2030 (USD MILLION)
TABLE 192. NIGERIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. NIGERIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. EGYPT SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 195. EGYPT SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 196. EGYPT SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 197. EGYPT SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 198. EGYPT SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2030 (USD MILLION)
TABLE 199. EGYPT SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. EGYPT SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. TURKEY SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 202. TURKEY SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 203. TURKEY SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 204. TURKEY SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 205. TURKEY SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2030 (USD MILLION)
TABLE 206. TURKEY SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. TURKEY SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 208. ISRAEL SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 209. ISRAEL SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 210. ISRAEL SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 211. ISRAEL SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 212. ISRAEL SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2030 (USD MILLION)
TABLE 213. ISRAEL SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. ISRAEL SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 215. NORWAY SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 216. NORWAY SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 217. NORWAY SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 218. NORWAY SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 219. NORWAY SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2030 (USD MILLION)
TABLE 220. NORWAY SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. NORWAY SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. POLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 223. POLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 224. POLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 225. POLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 226. POLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2030 (USD MILLION)
TABLE 227. POLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. POLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 229. SWITZERLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 230. SWITZERLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 231. SWITZERLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 232. SWITZERLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 233. SWITZERLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2030 (USD MILLION)
TABLE 234. SWITZERLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. SWITZERLAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 236. ASIA-PACIFIC SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 239. ASIA-PACIFIC SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 240. ASIA-PACIFIC SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2030 (USD MILLION)
TABLE 241. ASIA-PACIFIC SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 242. ASIA-PACIFIC SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 243. ASIA-PACIFIC SKIN CANCER DERMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 244. CHINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 245. CHINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 246. CHINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 247. CHINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 248. CHINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2030 (USD MILLION)
TABLE 249. CHINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. CHINA SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 251. INDIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 252. INDIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 253. INDIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 254. INDIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 255. INDIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2030 (USD MILLION)
TABLE 256. INDIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. INDIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 258. JAPAN SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 259. JAPAN SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 260. JAPAN SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 261. JAPAN SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 262. JAPAN SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2030 (USD MILLION)
TABLE 263. JAPAN SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. JAPAN SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 265. AUSTRALIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 266. AUSTRALIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 267. AUSTRALIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 268. AUSTRALIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 269. AUSTRALIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2030 (USD MILLION)
TABLE 270. AUSTRALIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. AUSTRALIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 272. SOUTH KOREA SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 273. SOUTH KOREA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 274. SOUTH KOREA SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 275. SOUTH KOREA SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 276. SOUTH KOREA SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2030 (USD MILLION)
TABLE 277. SOUTH KOREA SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 278. SOUTH KOREA SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 279. INDONESIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 280. INDONESIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 281. INDONESIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 282. INDONESIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 283. INDONESIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2030 (USD MILLION)
TABLE 284. INDONESIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 285. INDONESIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 286. THAILAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 287. THAILAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 288. THAILAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 289. THAILAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 290. THAILAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2030 (USD MILLION)
TABLE 291. THAILAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 292. THAILAND SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 293. PHILIPPINES SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 294. PHILIPPINES SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 295. PHILIPPINES SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 296. PHILIPPINES SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 297. PHILIPPINES SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2030 (USD MILLION)
TABLE 298. PHILIPPINES SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 299. PHILIPPINES SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 300. MALAYSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 301. MALAYSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 302. MALAYSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 303. MALAYSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 304. MALAYSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2030 (USD MILLION)
TABLE 305. MALAYSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 306. MALAYSIA SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 307. SINGAPORE SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 308. SINGAPORE SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 309. SINGAPORE SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 310. SINGAPORE SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 311. SINGAPORE SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2030 (USD MILLION)
TABLE 312. SINGAPORE SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 313. SINGAPORE SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 314. VIETNAM SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 315. VIETNAM SKIN CANCER DERMATOLOGY MARKET SIZE, BY TREATMENT MODALITY, 2018-2030 (USD MILLION)
TABLE 316. VIETNAM SKIN CANCER DERMATOLOGY MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
TABLE 317. VIETNAM SKIN CANCER DERMATOLOGY MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 318. VIETNAM SKIN CANCER DERMATOLOGY MARKET SIZE, BY IMMUNOTHERAPIES, 2018-2030 (USD MILLION)
TABLE 319. VIETNAM SKIN CANCER DERMATOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 320. VIETNAM SKIN CANCER DERMATOLOGY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 321. TAIWAN SKIN CANCER DERMATOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 322. TAIWA

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Skin Cancer Dermatology market report include:
  • Merck & Co., Inc.
  • Bristol-Myers Squibb Company
  • Roche Holding AG
  • Novartis AG
  • Amgen Inc.
  • AstraZeneca PLC
  • Pfizer Inc.
  • Sanofi S.A.
  • Eli Lilly and Company
  • GlaxoSmithKline plc

Table Information

Report AttributeDetails
No. of Pages189
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 9.03 Billion
Forecasted Market Value ( USD ) by 2030 $ 12.84 Billion
Compound Annual Growth Rate7.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Skin Cancer Diagnostics & Therapeutics Market by Therapeutic Approach, Diagnostic Type, Cancer Type, End User, Distribution Channel - Global Forecast to 2030 - Product Image

Skin Cancer Diagnostics & Therapeutics Market by Therapeutic Approach, Diagnostic Type, Cancer Type, End User, Distribution Channel - Global Forecast to 2030

  • Report
  • 190 Pages
  • Global
From
Actinic Keratosis Treatment - Global Strategic Business Report - Product Image

Actinic Keratosis Treatment - Global Strategic Business Report

  • Report
  • 354 Pages
  • Global
From
Ozone Therapy in Dermatology Market by Treatment Method, Product, Application, Distribution Channel, End-User - Global Forecast to 2030 - Product Image

Ozone Therapy in Dermatology Market by Treatment Method, Product, Application, Distribution Channel, End-User - Global Forecast to 2030

  • Report
  • 188 Pages
  • Global
From
Dermatology Drugs - Global Strategic Business Report - Product Image

Dermatology Drugs - Global Strategic Business Report

  • Report
  • 372 Pages
  • Global
From
Dermatology Treatment and Care Market (2024 Edition): Analysis By Treatment Type (Skin Disease and Care, Hair Disease and Care), By Route of Administration, By End User, By Region: Market Insights and Forecast (2020-2030) - Product Image

Dermatology Treatment and Care Market (2024 Edition): Analysis By Treatment Type (Skin Disease and Care, Hair Disease and Care), By Route of Administration, By End User, By Region: Market Insights and Forecast (2020-2030)

  • Report
  • 247 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.